Navellier & Associates’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
Other funds holding AORT
NAMI
VCM
PA
FAM
JIC
CCA
Navellier & Associates's AORT Position: Q1 2026 in Review
Navellier & Associates reduced its Artivion (AORT) stake by 2.8% in Q1 2026, selling an estimated $8.09K and leaving 7,222 shares worth $264K. The position accounts for 0.03% of the portfolio, ranked #292.
Navellier & Associates first reported a position in AORT in Q3 2025 and has held it in 3 quarters since. The position peaked at $450K in Q3 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.
- Navellier & Associates held 7,222 shares of Artivion worth $264K as of Q1 2026.
- Navellier & Associates sold 205 Artivion shares in Q1 2026, an estimated $8.09K.
- Artivion made up 0.03% of Navellier & Associates's portfolio in Q1 2026, its #292 holding.
- Navellier & Associates first reported a position in Artivion in Q3 2025 and has held it in 3 quarters since.
- Navellier & Associates's Artivion position peaked at $450K in Q3 2025.
- 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.
Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.